Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Maximum tolerated dose of ARRY-380 established in patients with breast cancer

Oct. 5, 2010

Plexxikon discloses new inhibitors of protein kinases

Oct. 5, 2010

Banyu and Merck & Co. discover new PKB inhibitors

Oct. 4, 2010

Aveo Pharmaceuticals regains worldwide rights to AV-299

Oct. 4, 2010

Data monitoring committee recommends continuation of phase III ThermoDox trial

Oct. 4, 2010

New inhibitors of C-raf/B-raf identified by Novartis

Oct. 4, 2010

Teva and Oncogenex begin second phase III custirsen trial in prostate cancer

Oct. 4, 2010

Astellas Pharma patents new 17-beta-HSD 5 inhibitors

Oct. 1, 2010

Unibioscreen claims novel cardiotonic steroid derivatives

Oct. 1, 2010

Medivation and Astellas begin phase III MDV-3100 trial in advanced prostate cancer

Oct. 1, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...